Procalcitonin Versus Serum Zinc for Diagnosis of Ventilator-Associated Pneumonia in ICU Patients
NCT07696897 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2026-07-10
Summary
Ventilator-associated pneumonia (VAP) is a common and serious infection among mechanically ventilated ICU patients. Early diagnosis remains challenging because clinical and radiological findings may lack specificity. Procalcitonin (PCT) is a well-established biomarker of bacterial infection, while serum zinc has recently emerged as a potential marker of immune dysfunction and infection severity. This prospective observational cohort study will compare the diagnostic accuracy of serum procalcitonin and serum zinc for the diagnosis of ventilator-associated pneumonia in 84 adult ICU patients. Diagnostic performance will be assessed using ROC curve analysis, sensitivity, specificity, positive predictive value, and negative predictive value. Associations between biomarker levels, inflammatory markers, disease severity scores, and clinical outcomes will also be evaluated.
Conditions
- Ventilator Acquired Pneumonia
Interventions
- DIAGNOSTIC_TEST
-
Serum Procalcitonin Measurement
Measurement of serum procalcitonin levels for evaluation of diagnostic accuracy in ventilator-associated pneumonia.
- DIAGNOSTIC_TEST
-
Serum Zinc Measurement
Measurement of serum zinc levels for evaluation of diagnostic accuracy in ventilator-associated pneumonia.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-07
- Primary Completion
- 2028-07-31
- Completion
- 2028-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis
NCT03506152 ·Status: COMPLETED
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia
NCT01018199 ·Status: WITHDRAWN ·Phase: NA
-
Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department
NCT02898948 ·Status: COMPLETED
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock
NCT03661268 ·Status: UNKNOWN ·Phase: NA
-
Procalcitonin as a Tool to Shorten Antibiotic Therapy in the ICU
NCT01494675 ·Status: COMPLETED ·Phase: NA
-
Early Diagnostic Biomarkers of Sepsis
NCT05112406 ·Status: UNKNOWN
-
Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.
NCT04479280 ·Status: COMPLETED
-
Biological Markers to Identify Early Sepsis and Acute Lung Injury
NCT00825357 ·Status: COMPLETED
-
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198 ·Status: NOT_YET_RECRUITING
-
Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis
NCT04203524 ·Status: TERMINATED ·Phase: NA
-
Diagnostic and Prognostic Value of Serial Procalcitonin (PCT) Measurements in Critically Ill Patients
NCT01362920 ·Status: COMPLETED
-
Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality
NCT00144638 ·Status: COMPLETED
-
Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.
NCT07200817 ·Status: RECRUITING
-
Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure
NCT02787603 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant
NCT03389360 ·Status: COMPLETED
-
Procalcitonin Levels in Patients With Fever and a Central Line
NCT01175005 ·Status: COMPLETED
-
Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU
NCT06395454 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis
NCT03097393 ·Status: COMPLETED
-
Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
NCT05083104 ·Status: UNKNOWN
-
Assessing Nutritional Status in Patients With Sepsis
NCT03906266 ·Status: COMPLETED ·Phase: NA
-
SEVERITY SCORE FOR COVID-19 PNEUMONIA
NCT04372199 ·Status: UNKNOWN
-
Can Measurement of Neutrophil-derived ROS Production be a Novel Biomarker of Sepsis?
NCT05968287 ·Status: COMPLETED
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN